Recruiting

PSMA Radioligands

Sponsor:

Jean-Mathieu Beauregard

Code:

NCT07940179

Conditions

Prostate Cancer

Other Cancers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PET PSMA tracer

Study Details

Brief summary:

The purpose of this study is to make non-approved PSMA radioligands available at CHU de Québec - Université Laval, while assessing their safety. Our hypothesis is that all the PSMA PET radioligand are safe, with a very low incidence of adverse events (AEs). The potential clinical impact of PSMA-PET will be explored in our clinical setting.

Conditions

Prostate Cancer

Other Cancers

Study ID

NCT07940179

Start date

Nov 4, 2021

Status verified date

Nov, 2026

Completion date

Dec 31, 2032

Anticipated

Primary completion date

Dec 31, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1\. Reception of a procedure request for PSMA-PET

Exclusion Criteria:

1. Incapacity to provide informed consent
2. Pregnancy, unless there has been a discussion between the participant and a nuclear medicine physician investigator about the potential clinical benefits vs. the potential risks for the fetus, in the context of the participant's medical condition, and that this discussion is documented in the nuclear medicine physician's clinical report.

Study Design

Enrollment

5000 participants

Anticipated

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

experimental: PSMA-PET

Interventions

PET PSMA tracer

Administration of a PSMA tracer for PET

Primary outcome measure

  • Proportion of Participants with PSMA PET radiopharmaceuticals-Related Adverse Events as Assessed by CTCAE v5.0 . [ Time Frame: up to 1 week ]

Central Contacts and Locations

Central contacts

Locations

CHU de Quebec-Université Laval

Recruiting

Québec, Quebec, Canada, G1R2J6

Contacts

Principal Investigator:

Jean-Mathieu Beauregard, MD

More Information

Sponsor

Jean-Mathieu Beauregard

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Keywords

  • prostate

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Jean-Mathieu Beauregard on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.